definiens: shallmean a product or service that serves substantially the same clinical need as a Licensed Solution . Notwithstanding theforegoing, [COMPANY] may continue to offer those Competitive Products on its menu of services as of the Effective Date andaccept requisitions for such products from its pathology customers so long as [COMPANY] is not actively promoting or marketingsuch Competitive Products ( e.g. distributing advertising materials or sponsoring presentations ) . If at any time Clarientdetermines ( in its sole and good faith discretion ) that the Prediction Sciences Algorithm no longer constitutes the bestavailable and most clinically relevant technology available in the market, then upon written notice from [COMPANY] to PredictionSciences ( a ) [COMPANY] ’s obligations under this Section 2.6 shall terminate, ( b ) the licenses granted to [COMPANY] in Sections 2.1and 2.5 shall convert from exclusive to nonexclusive and shall be limited to Licensed Solutions sold to repeat patients ofClarient ( i.e., those patients that have previously purchased a Licensed Solution from [COMPANY] ), and ( c ) the following sectionsshall terminate : 2.3, 2.4, 4, 6.3, 6.4 and 8.2